Wright Medical Group (WMGI) stock had a bullish inflow of $5.34 million worth of trades on uptick and an outflow of $3.92 million in downticks on Friday. The total uptick to downtick ratio stood at 1.36. The net money flow into the stock was $1.42 million. The money flow data, which is calculated as the dollar value of composite uptick minus the downtick trades indicated bullish. The block trades had a total money flow of $1.25 million. An inflow of $2.4 million block trade was recorded on downticks. $3.65 million of block trade during Uptick was observed, which shows continued buying by the smart money on every weakness. The total uptick to downtick ratio of block trades was 1.52 in favor of the bulls. However, Wright Medical Group (WMGI) stock traded down $0.17 , and reached $21.53, a drop of -0.78% over the previous day. On a weekly basis, the stock is 2.48%, over the previous weeks close.
Wright Medical Group (WMGI) : 13 Wall Street analysts covering Wright Medical Group (WMGI) believe that the average level the stock could reach for the short term is $26.31. The maximum price target given is $33 and the minimum target for short term is around $22, hence the standard deviation is calculated at $3.97.
Wright Medical Group (NASDAQ:WMGI): stock turned positive on Friday. Though the stock opened at $21.7, the bulls momentum made the stock top out at $21.75 level for the day. The stock recorded a low of $21.21 and closed the trading day at $21.72, in the green by 0.09%. The total traded volume for the day was 1,615,154. The stock had closed at $21.7 in the previous days trading.
In a related news,The officer (SVP, Process Improvement) of Wright Medical Group N.V., Walker Jennifer S. sold 1,167 shares at $19.34 on June 2, 2016. The Insider selling transaction had a total value worth of $22,570. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Companys business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Companys products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.